Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Donor safety in plasmapheresis

P Lundsgaard-Hansen

    Developments in Biological Standardization
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    European regulations limit plasmapheresis donations to 250 ml weekly, unlike US regulations allowing 1000 ml. High-volume donations may cause adverse health effects in donors, necessitating a review of current practices.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Safe hemoglobin or hematocrit levels in surgical patients.

    World journal of surgery·1996
    Same author

    Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass.

    The Journal of thoracic and cardiovascular surgery·1994
    Same author

    [Drug modification of blood loss].

    Klinische Anasthesiologie und Intensivtherapie·1993
    Same author

    Reply to invited letter concerning: Aprotinin (J Thorac Cardiovasc Surg 1991; 101:1103-4)

    The Journal of thoracic and cardiovascular surgery·1992
    Same author

    The 'critical hematocrit': a figure differing from patient to patient.

    Beitrage zur Infusionstherapie = Contributions to infusion therapy·1992
    Same author

    Treatment of acute blood loss.

    Vox sanguinis·1992
    Same journal

    International challenges and public policy issues.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in China.

    Developments in biological standardization·2000
    Same journal

    ICH activities on biotech topics.

    Developments in biological standardization·2000
    Same journal

    Regulation of biologicals in the European Union.

    Developments in biological standardization·2000
    Same journal

    Standardisation and licensing of combination vaccines based on DTP.

    Developments in biological standardization·2000
    Same journal

    Control of foot-and-mouth disease by vaccination.

    Developments in biological standardization·2000
    See all related articles

    Area of Science:

    • Transfusion Medicine
    • Immunology
    • Nephrology

    Background:

    • European and US regulations differ significantly regarding weekly plasma donation volumes.
    • Current US regulations permit a weekly donation volume of 1000 ml, which is four times the European limit of 250 ml.

    Purpose of the Study:

    • To evaluate the health implications of high-volume plasma donation under US regulations.
    • To compare the physiological impact of US versus European plasmapheresis guidelines.

    Main Methods:

    • Comparative analysis of regulatory guidelines for plasmapheresis.
    • Review of existing data on donor health outcomes related to plasma volume loss.
    • Assessment of protein levels and platelet aggregation in high-volume donors.

    Related Experiment Videos

    Main Results:

    • High-volume (1000 ml/week) plasma donation can lead to hypoproteinemia, hypoalbuminemia, and hypogammaglobulinemia.
    • These protein level changes are comparable to those seen in severe nephrotic syndrome.
    • Emerging data suggest a potential increase in platelet aggregation tendency in high-volume donors.

    Conclusions:

    • US plasmapheresis regulations may pose health risks to donors, including protein deficiencies and potential platelet issues.
    • European volume limitations should be considered to ensure donor safety.
    • Increasing the donor pool is recommended to meet plasma needs while adhering to safer volume limits.